Exact Mass: 442.2831
Exact Mass Matches: 442.2831
Found 500 metabolites which its exact mass value is equals to given mass value 442.2831
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ascorbyl stearate
Ascorbyl stearate is a preservative for margarine Ascorbyl stearate (C24H42O7) is an ester formed from ascorbic acid and stearic acid. In addition to its use as a source of vitamin C, it is used as an antioxidant food additive in margarine (E number E305). The USDA limits its use to 0.02\\% individually or in conjunction with other antioxidants Preservative for margarine
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea. 2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is a constituent of Tussilago farfara (coltsfoot). Constituent of Tussilago farfara (coltsfoot). 2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one is found in tea.
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one is found in mushrooms. (3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one is a constituent of Hypsizygus marmoreus (bunashimeji) and Pleurotus ostreatus (oyster mushroom)
Muzanzagenin
Muzanzagenin is found in green vegetables. Muzanzagenin is a constituent of the wild asparagus (Asparagus africanus) Constituent of the wild asparagus (Asparagus africanus). Muzanzagenin is found in green vegetables.
Prostaglandin G2 2-glyceryl Ester
Prostaglandin G2 2-glyceryl Ester is also known as 2-Glyceryl-prostaglandin g2. Prostaglandin G2 2-glyceryl Ester is considered to be practically insoluble (in water) and acidic
N-Docosahexaenoyl Asparagine
N-docosahexaenoyl asparagine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Asparagine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Asparagine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Asparagine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Alnespirone
DG(2:0/5-iso PGF2VI/0:0)
DG(2:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/2:0/0:0)
DG(5-iso PGF2VI/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/5-iso PGF2VI)
DG(2:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(5-iso PGF2VI/0:0/2:0)
DG(5-iso PGF2VI/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
9-Hydroxynerolidol-9-O-beta-D-glucopyranoside-2-O-acetate
14-phenoxytetradecanyl 3,5-dihydroxybenzoate|pistiphloro-glucinyl ester
3alpha-(5-methyldodeca-2E,4E,6E-trienoyloxy)-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one|3alpha-<5-methyldodeca-2E,4E,6E-trienoyloxy>-9alpha-hydroxy-10alphaH-eremophil-7(11)-ene-8-one
(2E,6E,10E)-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-5,12-diol|(2E,6E,10E,14E)-1-(1-hydroxy-4-methoxy-6-methyl phenyl)-5,12-dihydroxy-3,7,11,15-tetramethyl hexadeca-2,6,10,14-tetraene
10-(2,3-dihydro-5-hydroxy-7-methyl-1-benzofuran-2-yl)-10-hydroxy-6-methyl-2-(4-methyl-3-pentenyl)-(2E,6E)-undecadienoic acid|thunbergol B
Ac-12alpha-Hydroxy-24-methyl-24-oxo-16-scalaren-25-al-
(22R,24R)-22,24-epoxy-7,25-dihydroxyergosta-1,4-dien-3-one
(20S,22R)-1alpha,3beta-dihydroxy-witha-5,24-dienolide
22E-3beta-hydroxy-5alpha,6alpha,8alpha,14alpha-diepoxyergost-22-en-7-one
(16beta,22E)-16,18,20-Trihydroxy-24-methylcholesta-1,4,22-trien-3-one
petuniasterone C|petuniasterone C ( (22R,24S)-24,25-epoxy-7alpha,22-dihydroxyergosta-1,4-dien-3-one )
3-oxo-21alpha-ethoxy-24,25,26,27-tetranortirucall-7-ene-23(21)-lactone
(2R)-2,7,8-trimethyl-2-[(3E,7E)-4,8-dimethyl-13-hydroxy-12-hydroxymethyldeca-3,7,11-trienyl]chroman-6-ol|gamma-amplexichromanol
3-hexyl-6-(4-hydroxypentyl)-2H-pyran-2-on-4-O-beta-D-glucopyranoside|whitmanoside A
linalool-beta-D-glucopyranoside-2-O-acetate,6O-isovalerate
linalool-beta-D-glucopyranoside-2O-acetate-6O-<2-methylbutyrate>
(22S,25S)-17alpha,26-dihydroxy-22,25-epoxyfurost-4,6-dien-3-one|diosbulbisin D
22-acetylisocyclocitrinol A|22-O-acetylisocyclocitrinol A
5alpha,9alpha-epidioxy-8alpha,14alpha-epoxy-(22E)-ergosta-6,22-dien-3beta-ol|5??,9??-Epidioxy-8??,14??-epoxy-(22E)-ergosta-6,22-dien-3??-ol
(3beta,4beta)-3,4-dihydroxy-24,30-dinoroleana-12,20(29)-dien-28-oic acid|paeonenoide C
(2E,6E)-5-hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,14-trien-12-one|(2E,6E,14E)-1-(1-hydroxy-4-methoxy-6-methylphenyl)-5-hydroxy-12-one-3,7,11,15-tetramethyl hexadeca-2,6,14-triene|5-hydroxy-12-oxohalidrol
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid [IIN-based on: CCMSLIB00000848208]
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid [IIN-based: Match]
Ala Lys Lys Pro
Ala Lys Pro Lys
Ala Lys Pro Gln
Ala Lys Gln Pro
Ala Pro Lys Lys
Ala Pro Lys Gln
Ala Pro Gln Lys
Ala Gln Lys Pro
Ala Gln Pro Lys
Ile Ile Pro Thr
Ile Ile Thr Pro
Ile Ile Val Val
Ile Leu Pro Thr
Ile Leu Thr Pro
Ile Leu Val Val
Ile Pro Ile Thr
Ile Pro Leu Thr
Ile Pro Thr Ile
Ile Pro Thr Leu
Ile Thr Ile Pro
Ile Thr Leu Pro
Ile Thr Pro Ile
Ile Thr Pro Leu
Ile Val Ile Val
Ile Val Leu Val
Ile Val Val Ile
Ile Val Val Leu
Lys Ala Lys Pro
Lys Ala Pro Lys
Lys Ala Pro Gln
Lys Ala Gln Pro
Lys Lys Ala Pro
Lys Lys Pro Ala
Lys Pro Ala Lys
Lys Pro Ala Gln
Lys Pro Lys Ala
Lys Pro Gln Ala
Lys Gln Ala Pro
Lys Gln Pro Ala
Leu Ile Pro Thr
Leu Ile Thr Pro
Leu Leu Pro Thr
Leu Leu Thr Pro
Leu Pro Ile Thr
Leu Pro Leu Thr
Leu Pro Thr Ile
Leu Pro Thr Leu
Leu Thr Ile Pro
Leu Thr Leu Pro
Leu Thr Pro Ile
Leu Thr Pro Leu
Pro Ala Lys Lys
Pro Ala Lys Gln
Pro Ala Gln Lys
Pro Ile Ile Thr
Pro Ile Leu Thr
Pro Ile Thr Ile
Pro Ile Thr Leu
Pro Lys Ala Lys
Pro Lys Ala Gln
Pro Lys Lys Ala
Pro Lys Gln Ala
Pro Leu Ile Thr
Pro Leu Leu Thr
Pro Leu Thr Ile
Pro Leu Thr Leu
Pro Gln Ala Lys
Pro Gln Lys Ala
Pro Thr Ile Ile
Pro Thr Ile Leu
Pro Thr Leu Ile
Pro Thr Leu Leu
Gln Ala Lys Pro
Gln Ala Pro Lys
Gln Lys Ala Pro
Gln Lys Pro Ala
Gln Pro Ala Lys
Gln Pro Lys Ala
Thr Ile Ile Pro
Thr Ile Leu Pro
Thr Ile Pro Ile
Thr Ile Pro Leu
Thr Leu Ile Pro
Thr Leu Leu Pro
Thr Leu Pro Ile
Thr Leu Pro Leu
Thr Pro Ile Ile
Thr Pro Ile Leu
Thr Pro Leu Ile
Thr Pro Leu Leu
(5Z,7E)-(1S,3R,20R,22S)-24a-homo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R)-18-(4-hydroxy-4-methyl-2-pentynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
Muzanzagenin
4-[(2,5-dioxo-4-Imidazolidinylidene)methyl)-benzaldehyde
2,9-Bis(3-methyl-2E-pentenoyl)-2b,9a-dihydroxy-4Z,10(14)-oplopadien-3-one
(22S)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a-homo-20-epivitamin D3
(2S)-3,4,4,4-tetradeuterio-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]-3-(trideuteriomethyl)butanoic acid
Mazipredone
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
tert-butyl N-[6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexyl]carbamate
N,N-Dibenzyl-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane
Dotarizine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
trans,trans-4-(4-Pentyl-bicyclohexyl-4-yl)-3,4,5-trifluorobiphenyl
N-(2-aminoethyl)ethane-1,2-diamine,dimethyl-bis(oxiran-2-ylmethyl)azanium,hexanedioic acid,chloride
(S)-1-((S)-3,3-Dimethyl-2-((S)-2-(methylamino)propanamido)butanoyl)-N-((R)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide
8-[4-[Propyl(5-methoxychroman-3-yl)amino]butyl]-8-azaspiro[4.5]decane-7,9-dione
(3beta,5alpha,9alpha,22E,24R)-5,9-Epidioxy-3-hydroxyergosta-7,22-dien-6-one
(2E,6E,10E)-1-(2,5-dihydroxy-3-methylphenyl)-13-(3,3-dimethyloxiran-2-yl)-12-hydroxy-3,7,11-trimethyltrideca-2,6,10-trien-5-one
3alpha,7alpha-Dihydroxy-5beta-cholane-24-sulfonic acid
2-(1-adamantyl)-N-[2,5-diethoxy-4-(4-morpholinyl)phenyl]acetamide
4-[3-methyl-5-(5,6,7-trihydroxy-1,2,4a,5-tetramethyl-3,4,6,7,8,8a-hexahydro-2H-naphthalen-1-yl)pentoxy]-4-oxobutanoic acid
1-[[(2S,3S)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3R)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3R)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[3-methyl-2-[2-(methylamino)propanoylamino]pentanoyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide
2,3-Dihydroxypropyl (2-hydroxy-3-tetradecoxypropyl) hydrogen phosphate
(5R,6S,9S,11R,13S,15S,16S,17R,19S,21S)-6,21-dimethyl-21-(4-methyl-3-methylidenepentyl)-14,18,20-trioxaheptacyclo[15.4.1.02,16.02,19.05,15.06,11.013,15]docosan-9-ol
Prostaglandin G2 2-glyceryl Ester
A 2-monoglyceride obtained by formal condensation of the carboxy group of prostaglandin G2 with the 2-hydroxy group of glycerol.
methyl (1r,2r,3s,6s,7s)-3-[(2e,5s)-1-(acetyloxy)-5,6-dihydroxy-6-methylhept-2-en-2-yl]-1,7-dihydroxy-6-methylbicyclo[4.3.1]decane-2-carboxylate
17-(hydroxymethyl)-7-(4-hydroxyphenyl)-2,10-dimethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-ol
12-[(2e)-4-(2,5-dihydroxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-10-hydroxy-6,6,9,9-tetramethyl-8-oxabicyclo[5.4.1]dodec-1(12)-en-2-one
methyl 3-[(1s,4ar,5s,6s,8ar)-5-[(2,5-dihydroxy-3-methylphenyl)methyl]-5,6,8a-trimethyl-2-(propan-2-ylidene)-hexahydro-1h-naphthalen-1-yl]propanoate
4-hydroxy-3-{[2-(3-hydroxy-2-methylprop-1-en-1-yl)-5a,9b-dimethyl-7-methylidene-octahydro-1h-naphtho[2,1-b]furan-6-yl]methyl}-5,6-dimethylpyran-2-one
2,4,6,9,14,16-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-3-yl propanoate
4,5-dihydroxy-2-[(10-hydroxy-2,6,10-trimethyldodeca-2,6,11-trien-4-yl)oxy]-6-(hydroxymethyl)oxan-3-yl acetate
(1r,3as,3bs,4r,9ar,9bs,11ar)-4-hydroxy-1-[(2s,3r)-3-hydroxy-4-[(2s)-2,3,3-trimethyloxiran-2-yl]butan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(2e,6e,13e)-1-(2,5-dihydroxy-3-methylphenyl)-15-hydroxy-3,7,11,15-tetramethylhexadeca-2,6,13-triene-5,12-dione
3-formyl-4-[3-(3-hydroxy-4-methylphenyl)-3-oxopropyl]-3,4a,8,8-tetramethyl-hexahydro-1h-naphthalen-1-yl acetate
(6e,10e,14e)-16-(2,5-dihydroxy-3-methylphenyl)-1,12-dihydroxy-2,6,10,14-tetramethylhexadeca-2,6,10,14-tetraen-4-one
[(2r,4ar,8ar)-2-[(1s,2r,4as,8as)-2-hydroxy-2,5,5,8a-tetramethyl-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl]-7-methyl-6-oxo-2,4a,5,8a-tetrahydrochromen-4-yl]methyl acetate
(2s,4's,4'ar,4'bs,7's,8'ar,10'ar)-4',7'-dihydroxy-2',4'b,6,7,8',8',10'a-heptamethyl-4',4'a,5',6',7',8'a,9',10'-octahydro-3h-spiro[furo[3,2-c]pyran-2,1'-phenanthren]-4-one
(7s,10r)-10-hydroxy-12-{[(2s)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]methyl}-6,6,9,9-tetramethyl-8-oxabicyclo[5.4.1]dodec-1(12)-en-2-one
(1r,2r,4ar,6r,7s,8ar)-6-hydroxy-1,8a-dimethyl-5-oxo-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl (2e,4e,6e)-5-methyldodeca-2,4,6-trienoate
(3s,4e)-2-hydroxy-2-[(2r,5s,6s,9r,13s,15s)-15-hydroxy-5-methyl-12-oxotetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-6-yl]hex-4-en-3-yl acetate
6-dodecyl-11-(3-methylbutyl)-4,12-dioxatricyclo[7.4.0.0³,⁷]trideca-1(9),2,7-triene-5,13-dione
8-acetyl-7-formyl-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,7,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate
2-(10-hydroxy-9-methoxy-4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2,8-dimethyl-3,4-dihydro-1-benzopyran-6-ol
ethyl 2-{5-[2-({2-[5-(2-hydroxybutyl)oxolan-2-yl]propanoyl}oxy)butyl]oxolan-2-yl}propanoate
3-{[(3r,3ar,5ar,6r,7r,9as,9br)-3-carboxy-3,3a,6,7,9a-pentamethyl-octahydro-1h-cyclopenta[a]naphthalen-6-yl]methyl}-4-hydroxybenzoic acid
2-[(1r,2r,5r)-2-[(1as,4as,7s,8ar)-7-hydroxy-4a-methyl-4-oxo-1ah,5h,6h,7h,8h-naphtho[1,8a-b]oxiren-3-yl]-5-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-1-methylcyclopentyl]acetaldehyde
(4e)-6-(2,5-dihydroxy-3-methylphenyl)-1-{2-[(2z)-4-hydroxy-4-methylpent-2-enoyl]-1,2-dimethylcyclopentyl}-4-methylhex-4-en-2-one
15-(5,6-dimethylhept-3-en-2-yl)-9,18-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-4-en-3-one
6,21-dimethyl-21-(4-methyl-3-methylidenepentyl)-14,18,20-trioxaheptacyclo[15.4.1.0²,¹⁶.0²,¹⁹.0⁵,¹⁵.0⁶,¹¹.0¹³,¹⁵]docosan-9-ol
(1s,3z,3as,4s,6r,7ar)-3-ethylidene-4-isopropyl-7-methylidene-6-{[(2e)-3-methylpent-2-enoyl]oxy}-2-oxo-hexahydroinden-1-yl (2e)-3-methylpent-2-enoate
(4z)-6-(2,5-dihydroxy-3-methylphenyl)-1-[(1s,2s)-2-[(2e)-4-hydroxy-4-methylpent-2-enoyl]-1,2-dimethylcyclopentyl]-4-methylhex-4-en-2-one
3,4,6,7,9,14-hexahydroxy-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁸]hexadecan-16-yl propanoate
(3as,4r,7ar)-5-(2-hydroxy-2-methylpropyl)-6-[(2e)-4-(2-hydroxy-5-methoxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-3a,7a-dimethyl-2,3,4,7-tetrahydro-1h-inden-4-ol
5α,9α-epidioxy-8α,14α-epoxy-(22e)-ergosta-6,22-dien-3β-ol
{"Ingredient_id": "HBIN011401","Ingredient_name": "5\u03b1,9\u03b1-epidioxy-8\u03b1,14\u03b1-epoxy-(22e)-ergosta-6,22-dien-3\u03b2-ol","Alias": "NA","Ingredient_formula": "C28H42O4","Ingredient_Smile": "CC(C)C(C)C=CC(C)C1CCC23C1(CCC45C2(O3)C=CC6(C4(CCC(C6)O)C)OO5)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6897","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}